Public Firm Sonnet BioTherapeutics to Launch HyperLiquid Treasury in New Deal
Nasdaq-listed Sonnet BioTherapeutics, Inc. is set to merge with Rorschach I LLC to become Hyperliquid Strategies, Inc.
As a new single entity, they will launch a HYPE
HYPE
...